Point72 DIFC Ltd Invests $1.60 Million in The Cooper Companies, Inc. (NASDAQ:COO)

Point72 DIFC Ltd acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COOFree Report) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 18,330 shares of the medical device company’s stock, valued at approximately $1,600,000.

A number of other hedge funds have also recently bought and sold shares of COO. Benjamin F. Edwards & Company Inc. boosted its holdings in shares of Cooper Companies by 248.6% in the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 244 shares of the medical device company’s stock valued at $25,000 after purchasing an additional 174 shares during the last quarter. Brown Brothers Harriman & Co. increased its stake in Cooper Companies by 412.2% during the fourth quarter. Brown Brothers Harriman & Co. now owns 251 shares of the medical device company’s stock worth $95,000 after acquiring an additional 202 shares during the last quarter. Covestor Ltd raised its holdings in shares of Cooper Companies by 305.9% in the 1st quarter. Covestor Ltd now owns 276 shares of the medical device company’s stock worth $28,000 after purchasing an additional 208 shares during the period. Innealta Capital LLC acquired a new position in shares of Cooper Companies in the 2nd quarter valued at about $25,000. Finally, Crewe Advisors LLC grew its holdings in shares of Cooper Companies by 286.4% during the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock worth $30,000 after purchasing an additional 252 shares during the period. Institutional investors and hedge funds own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on COO. Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a report on Thursday, August 29th. Robert W. Baird increased their price target on Cooper Companies from $118.00 to $125.00 and gave the company an “outperform” rating in a report on Thursday, August 29th. Piper Sandler upped their target price on Cooper Companies from $115.00 to $120.00 and gave the stock an “overweight” rating in a research report on Thursday, August 29th. Wells Fargo & Company increased their target price on Cooper Companies from $110.00 to $115.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Finally, Stifel Nicolaus reissued a “buy” rating and set a $115.00 price target (up from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Four research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $115.00.

Get Our Latest Analysis on COO

Cooper Companies Trading Up 0.0 %

Cooper Companies stock opened at $109.85 on Wednesday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.18 and a current ratio of 1.99. The Cooper Companies, Inc. has a 1 year low of $75.93 and a 1 year high of $112.38. The firm’s 50-day moving average is $98.75 and its 200-day moving average is $95.56. The company has a market cap of $21.87 billion, a P/E ratio of 64.62, a PEG ratio of 2.60 and a beta of 0.98.

Cooper Companies (NASDAQ:COOGet Free Report) last announced its quarterly earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.05. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The business had revenue of $1 billion for the quarter, compared to analysts’ expectations of $997.30 million. During the same period in the prior year, the firm earned $0.84 EPS. The business’s quarterly revenue was up 7.8% on a year-over-year basis. On average, equities analysts expect that The Cooper Companies, Inc. will post 3.66 earnings per share for the current year.

Insider Buying and Selling at Cooper Companies

In related news, CEO Albert G. White III sold 114,992 shares of the stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the transaction, the chief executive officer now directly owns 165,273 shares of the company’s stock, valued at approximately $18,267,624.69. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CEO Albert G. White III sold 114,992 shares of the company’s stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the completion of the sale, the chief executive officer now owns 165,273 shares of the company’s stock, valued at $18,267,624.69. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Agostino Ricupati sold 1,601 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the transaction, the chief accounting officer now directly owns 4,818 shares in the company, valued at approximately $520,488.54. The disclosure for this sale can be found here. Insiders sold 256,373 shares of company stock valued at $27,637,427 in the last ninety days. Company insiders own 2.00% of the company’s stock.

Cooper Companies Company Profile

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Featured Articles

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.